Product Details
| Product Name: Orlistat | CAS No.: 96829-58-2 |
| EC-No.: 639-755-1 | Min. Order: 1Kg/Bag |
| Purity: USP37 / 98.5% | Supply Ability: 20 tons |
| Release date: 2026/06/03 |
Product Information
| roduct Name: | Orlistat |
| Synonyms: | (S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID (S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYL ESTER;RO-18-0647;(-)-TETRAHYDROLIPSTATIN;ORLISTAT;N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;Orlistat(synthetase/compound);Orlistat(synthesis);Orlistat(FerMentation) |
| CAS: | 96829-58-2 |
| MF: | C29H53NO5 |
| MW: | 495.73 |
| EINECS: | 639-755-1 |
| Product Categories: | Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceutical Raw Materials;Miscellaneous Biochemicals;API;Pharmaceuticals;Antiobesity Agent;Amino Acids & Derivatives;Heterocycles;ACTOS;Other APIs;Lipid-lowering medicine reducing weight |
| Mol File: | 96829-58-2.mol |
Usage
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost. It reduces the incidence of diabetes type II in people who are obese around the same amount that lifestyle changes do. Long-term use of orlistat also leads to a very modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
Company Information

Company Profile Introduction
You may like
-
CAS:117976-90-6
-
CAS:58306-30-2
-
CAS:72432-03-2
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-04 | ||
| $2.00 |
VIP3Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2026-06-04 | |
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-06-04 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-06-04 | |
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-03 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-06-02 | ||
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2026-05-29 | ||
|
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-05-20 | ||
| $1270.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-05-15 | |
| $52.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
- Since: 1996-07-16
- Address: 16F,HUICHENG COMM,839 XIAHE ROAD,XIAMEN CHINA

China